Cargando…

Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning

Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumagai, Koji, Okamura, Terue, Toyoda, Masao, Senzaki, Hideto, Watanabe, Chihiro, Ohmichi, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751651/
https://www.ncbi.nlm.nih.gov/pubmed/23938043
http://dx.doi.org/10.1186/1477-7819-11-184
_version_ 1782281642051633152
author Kumagai, Koji
Okamura, Terue
Toyoda, Masao
Senzaki, Hideto
Watanabe, Chihiro
Ohmichi, Masahide
author_facet Kumagai, Koji
Okamura, Terue
Toyoda, Masao
Senzaki, Hideto
Watanabe, Chihiro
Ohmichi, Masahide
author_sort Kumagai, Koji
collection PubMed
description Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusively using (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT), and treated by low anterior resection with total mesorectal excision aiming for macroscopic complete resection. The treatment goals for the patient were gradually changed from curative to palliative chemotherapy; she survived for 45 months without rectal obstruction after secondary debulking surgery, and was followed up until autopsy. Thus, (18)F-FDG PET/CT may be valuable for detecting rectal lymph node metastasis and can play an essential role in planning treatment for recurrent ovarian carcinoma.
format Online
Article
Text
id pubmed-3751651
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37516512013-08-24 Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning Kumagai, Koji Okamura, Terue Toyoda, Masao Senzaki, Hideto Watanabe, Chihiro Ohmichi, Masahide World J Surg Oncol Case Report Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusively using (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT), and treated by low anterior resection with total mesorectal excision aiming for macroscopic complete resection. The treatment goals for the patient were gradually changed from curative to palliative chemotherapy; she survived for 45 months without rectal obstruction after secondary debulking surgery, and was followed up until autopsy. Thus, (18)F-FDG PET/CT may be valuable for detecting rectal lymph node metastasis and can play an essential role in planning treatment for recurrent ovarian carcinoma. BioMed Central 2013-08-12 /pmc/articles/PMC3751651/ /pubmed/23938043 http://dx.doi.org/10.1186/1477-7819-11-184 Text en Copyright ©2013 Kumagai et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kumagai, Koji
Okamura, Terue
Toyoda, Masao
Senzaki, Hideto
Watanabe, Chihiro
Ohmichi, Masahide
Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning
title Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning
title_full Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning
title_fullStr Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning
title_full_unstemmed Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning
title_short Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning
title_sort rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)f-fdg pet/ct in treatment planning
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751651/
https://www.ncbi.nlm.nih.gov/pubmed/23938043
http://dx.doi.org/10.1186/1477-7819-11-184
work_keys_str_mv AT kumagaikoji rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning
AT okamuraterue rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning
AT toyodamasao rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning
AT senzakihideto rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning
AT watanabechihiro rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning
AT ohmichimasahide rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning